Analyzing nearly 500,000 single cells, researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are refining how to classify colorectal cancer and identify new targets to develop effective therapies.
After a year of work to bring balance to an equation that measures kidney function by removing racial variables, Sharon Moe, MD, associate dean for clinical and translational medicine and director of the Division of Nephrology for Indiana University School of Medicine, is celebrating a nationally adopted change in how the glomerular filtration rate (GFR) is being calculated to improve patient lives.
Using the nation’s largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected most cancer patients from getting COVID.
Experts at Indiana University School of Medicine have helped identify that a common protein found in neurodegenerative diseases forms amyloid filaments in an age-dependent manner without a connection to disease.
Indiana University School of Medicine researchers found that niacin limits Alzheimer’s disease progression when used in models in the lab, a discovery that could potentially pave the way toward therapeutic approaches to the disease.
Researchers from Indiana University School of Medicine Department of Microbiology and Immunology are studying new ways to treat seasonal or intermittent asthma. Their findings were recently published in Science Immunology.
Researchers are investigating novel regenerative medicine approaches to better manage vascular health complications from type 2 diabetes that could someday support blood vessel repair in the eye among diabetic patients with early retinal vascular dysfunction.
Researchers at Indiana University School of Medicine Department of Microbiology and Immunology have made an important new discovery about how a particular molecule could improve lung function for people with asthma and food allergies.